Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

FliC's Hypervariable D3 Domain Is Required for Robust Anti-Flagellin Primary Antibody Responses.

López-Yglesias AH, Lu CC, Zhao X, Chou T, VandenBos T, Strong RK, Smith KD.

Immunohorizons. 2019 Sep 5;3(9):422-432. doi: 10.4049/immunohorizons.1800061.

PMID:
31488506
2.

Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway.

López-Yglesias AH, Zhao X, Quarles EK, Lai MA, VandenBos T, Strong RK, Smith KD.

J Immunol. 2014 Feb 15;192(4):1587-96. doi: 10.4049/jimmunol.1301893. Epub 2014 Jan 17.

3.

Orientation of mineral crystallites and mineral density during skeletal development in mice deficient in tissue nonspecific alkaline phosphatase.

Tesch W, Vandenbos T, Roschgr P, Fratzl-Zelman N, Klaushofer K, Beertsen W, Fratzl P.

J Bone Miner Res. 2003 Jan;18(1):117-25.

4.

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.

Sutherland CL, Chalupny NJ, Schooley K, VandenBos T, Kubin M, Cosman D.

J Immunol. 2002 Jan 15;168(2):671-9.

5.

Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma.

Ahdieh M, Vandenbos T, Youakim A.

Am J Physiol Cell Physiol. 2001 Dec;281(6):C2029-38.

6.

A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.

Born TL, Morrison LA, Esteban DJ, VandenBos T, Thebeau LG, Chen N, Spriggs MK, Sims JE, Buller RM.

J Immunol. 2000 Mar 15;164(6):3246-54.

7.

Blood circulation as source for osteopontin in acellular extrinsic fiber cementum and other mineralizing tissues.

VandenBos T, Bronckers AL, Goldberg HA, Beertsen W.

J Dent Res. 1999 Nov;78(11):1688-95.

PMID:
10576164
8.
9.

A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR.

Comeau MR, Johnson R, DuBose RF, Petersen M, Gearing P, VandenBos T, Park L, Farrah T, Buller RM, Cohen JI, Strockbine LD, Rauch C, Spriggs MK.

Immunity. 1998 Apr;8(4):473-82.

10.

Molecular characterization of the human interleukin (IL)-17 receptor.

Yao Z, Spriggs MK, Derry JM, Strockbine L, Park LS, VandenBos T, Zappone JD, Painter SL, Armitage RJ.

Cytokine. 1997 Nov;9(11):794-800.

PMID:
9367539
11.

LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain.

Kozlosky CJ, VandenBos T, Park L, Cerretti DP, Carpenter MK.

Cytokine. 1997 Aug;9(8):540-9.

PMID:
9245480
12.

Cell-cell adhesion mediated by binding of membrane-anchored ligand LERK-2 to the EPH-related receptor human embryonal kinase 2 promotes tyrosine kinase activity.

Böhme B, VandenBos T, Cerretti DP, Park LS, Holtrich U, Rübsamen-Waigmann H, Strebhardt K.

J Biol Chem. 1996 Oct 4;271(40):24747-52.

13.

Ligands for EPH-related tyrosine kinase receptors are developmentally regulated in the CNS.

Carpenter MK, Shilling H, VandenBos T, Beckmann MP, Cerretti DP, Kott JN, Westrum LE, Davison BL, Fletcher FA.

J Neurosci Res. 1995 Oct 1;42(2):199-206.

PMID:
8568920
14.

Ligands for the receptor tyrosine kinases hek and elk: isolation of cDNAs encoding a family of proteins.

Kozlosky CJ, Maraskovsky E, McGrew JT, VandenBos T, Teepe M, Lyman SD, Srinivasan S, Fletcher FA, Gayle RB 3rd, Cerretti DP, et al.

Oncogene. 1995 Jan 19;10(2):299-306.

PMID:
7838529
15.

Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

Goodwin RG, Alderson MR, Smith CA, Armitage RJ, VandenBos T, Jerzy R, Tough TW, Schoenborn MA, Davis-Smith T, Hennen K, et al.

Cell. 1993 May 7;73(3):447-56.

PMID:
8387892
16.

Recombinant soluble IgA Fc receptor: generation, biochemical characterization, and functional analysis of the recombinant protein.

Maliszewski CR, VandenBos T, Shen L, Schoenborn MA, Kubagawa H, Beckmann MP, Monteiro RC.

J Leukoc Biol. 1993 Mar;53(3):223-32.

PMID:
8454945
17.

Reconstitution of high affinity leukaemia inhibitory factor (LIF) receptors in haemopoietic cells transfected with the cloned human LIF receptor.

Gearing DP, VandenBos T, Beckmann MP, Thut CJ, Comeau MR, Mosley B, Ziegler SF.

Ciba Found Symp. 1992;167:245-55; discussion 255-9. Review.

PMID:
1425017
18.

Molecular characterization of the interleukin-8 receptor.

Beckmann MP, Munger WE, Kozlosky C, VandenBos T, Price V, Lyman S, Gerard NP, Gerard C, Cerretti DP.

Biochem Biophys Res Commun. 1991 Sep 16;179(2):784-9.

PMID:
1898400
19.

Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptor.

Jacobs CA, Lynch DH, Roux ER, Miller R, Davis B, Widmer MB, Wignall J, VandenBos T, Park LS, Beckmann MP.

Blood. 1991 Jun 1;77(11):2396-403.

PMID:
2039820
20.

A soluble form of the interleukin 4 receptor in biological fluids.

Fanslow WC, Clifford K, VandenBos T, Teel A, Armitage RJ, Beckmann MP.

Cytokine. 1990 Nov;2(6):398-401.

PMID:
2104233
21.

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, Friend D, Alpert A, Anderson D, Jackson J, et al.

Cell. 1989 Oct 20;59(2):335-48.

PMID:
2805066

Supplemental Content

Loading ...
Support Center